Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 246

The DOI matches its Crossref record.

Vancomycin Added to Empirical Combination Antibiotic Therapy for Fever in Granulocytopenic Cancer Patients

European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group, National Cancer Institute of Canada-Clinical Trials Group·1991·Journal of Infectious Diseases

Abstract

A total of 747 febrile granulocytopenic patients with cancer were randomized to receive ceftazidime plus amikacin (CA)with or without vancomycin (V) as initial empirical therapy. Single gram-positive bacteremias responded in 29(43%)of68 patients treated with CA and in 48(72%) of 67 treated with CAV (P = .(01). For single gram-negative bacteremias and clinically documented and possible infections the response rates of CA and CAV were 80% and 63%(P = .17), 55% and 75%(P = .009), and 74% and 81% (P = .16), respectively. However, for patients with grampositive bacteremia and for all other patients, there were no differences by treatment regimens in the proportion of febrile patients on each trial day (P = .85, P = .82, respectively) or in the duration of fever (P = .22, P = 93, respectively). Moreover, no patient with gram-positive bacteremia died during the first 3 days of true empirical therapy. Antibiotic-associated nephrotoxicity was more frequent in patients treated with vancomycin (6%vs. 2%, P =.02). These results do not support the empirical addition of vancomycin to initial antibiotic therapy in cancer patients with fever and granulocytopenia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/163.5.951

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 246

Metadata

Authors
European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group, & National Cancer Institute of Canada-Clinical Trials Group
Venue
Journal of Infectious Diseases
Published
1991-05-01
Volume
163
Issue
5
Pages
951-958
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W4238546275
Cited by
246
References
0
FWCI
6.13
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vancomycin Added to Empirical Combination Antibiotic Therapy for Fever in Granulocytopenic Cancer Patients. https://app.cochat.ai/papers/10.1093/infdis/163.5.951
The paper
European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group, & National Cancer Institute of Canada-Clinical Trials Group. (1991). Vancomycin Added to Empirical Combination Antibiotic Therapy for Fever in Granulocytopenic Cancer Patients. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/163.5.951

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.